kujimycin B: macrolide antibiotics isolated from various strains of Streptomyces; many have significant activity against some Gram positive bacteria; kujimycins was minor descriptor (76-84); on-line & Index Medicus search ERYTHROMYCIN/AA (76-84) [MeSH]
Lankamycin : no description available [CHeBI]
ID Source | ID |
---|---|
PubMed CID | 15560071 |
CHEBI ID | 80017 |
MeSH ID | M0262809 |
Synonym |
---|
lankavamycin |
kujimycin b |
a-20338-n2 |
antibiotic a-20338-n2 |
lankamycin |
30042-37-6 |
unii-68dqy2p51c |
68dqy2p51c , |
CHEBI:80017 |
lankamycin [mi] |
Q27149163 |
(2r,3s,4s,5r,7s,9s,10s,11r,12s,13r)-12-(((2r,4r,5r,6s)-5-acetoxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-7-hydroxy-10-(((2s,3r,4s,6r)-3-hydroxy-4-methoxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2-((2s,3s)-3-hydroxybutan-2-yl)-3,5,7,9,11,13-hexam |
[(2r,3s,4s,5r,7s,9s,10s,11r,12s,13r)-12-[(2r,4r,5r,6s)-5-acetyloxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-hydroxy-2-[(2s,3s)-3-hydroxybutan-2-yl]-10-[(2s,3r,4s,6r)-3-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-oxacyclotetrad |
Class | Description |
---|---|
macrolide | A macrocyclic lactone with a ring of twelve or more members derived from a polyketide. |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 7 (36.84) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 3 (15.79) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.26%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 18 (94.74%) | 84.16% |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|